-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Phio Pharmaceuticals Corp. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2024.
- Phio Pharmaceuticals Corp. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 990K shares, a 265% increase year-over-year.
- Phio Pharmaceuticals Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 2.08M shares, a 83.3% increase from 2022.
- Phio Pharmaceuticals Corp. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.14M shares, a 6.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)